07 Dec Potential Missing Professional Information (PI) and Patient Information Leaflet (PIL) in Folding Boxes of Hemlibra® 60 mg/0,4 mL solution for injection (emicizumab):
Posted at 09:20h
in
Dear Healthcare Professional
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Products (Pty) Ltd would like to inform you of the potential missing PI and PIL in folding boxes of Hemlibra® (emicizumab) 60 mg/0,4 mL solution for injection. The purpose of this communication is to clarify that the product can still be used and to provide copies of the relevant PI and PIL.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
30/11/2023
File Type:
pdf
Category:
Communication To Health Care Professionals